According to The Insight Partners, Human Vaccine Adjuvants Market is projected to grow from US$ 1,571.41 million in 2022 to US$ 4,489.23 million by 2030, registering a strong CAGR of 14.0% during the forecast period. This remarkable growth reflects the rising importance of adjuvants in enhancing vaccine efficacy and improving immune responses across a wide range of diseases. The global...